A Review of the Cardiac and Cardiovascular Effects of COVID-19 in Adults and Children.
Angiotensin-converting enzyme 2
COVID-19/complications
SARS-CoV-2
biomarkers
cardiovascular diseases/epidemiology/etiology/physiopathology/virology
comorbidity
coronavirus infections/complications
cytokines/blood
disease progression
myocarditis/etiology
Journal
Texas Heart Institute journal
ISSN: 1526-6702
Titre abrégé: Tex Heart Inst J
Pays: United States
ID NLM: 8214622
Informations de publication
Date de publication:
01 07 2021
01 07 2021
Historique:
entrez:
2
8
2021
pubmed:
3
8
2021
medline:
7
8
2021
Statut:
ppublish
Résumé
Symptomatic coronavirus disease 2019 (COVID-19) typically affects the respiratory system but can involve the cardiovascular system. Cardiac complications of COVID-19 can result directly from myocarditis or indirectly from numerous other mechanisms. Differentiating between primary and secondary cardiovascular involvement-our focus in this review-may help to identify the long-term effects of COVID-19 on the heart in adults and children.
Identifiants
pubmed: 34340244
pii: 468681
doi: 10.14503/THIJ-20-7395
pmc: PMC8367289
pii:
doi:
Types de publication
Journal Article
Comment
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : CommentOn
Informations de copyright
© 2021 by the Texas Heart® Institute, Houston.
Références
JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
Cardiovasc Res. 2020 May 1;116(6):1097-1100
pubmed: 32227090
J Clin Med. 2019 Feb 12;8(2):
pubmed: 30759844
Fetal Pediatr Pathol. 2020 Jun;39(3):263-268
pubmed: 32401577
Infect Immun. 2004 Aug;72(8):4410-5
pubmed: 15271897
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
J Infect Dis. 2020 Jan 2;221(2):256-266
pubmed: 31693113
Eur Heart J. 2021 Jan 7;42(2):206
pubmed: 32176300
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):317-325
pubmed: 32464637
J Virol. 2019 Mar 5;93(6):
pubmed: 30626688
Life Sci. 2020 Sep 1;256:117905
pubmed: 32504757
Circulation. 2020 Aug 4;142(5):429-436
pubmed: 32418446
Chin Med J (Engl). 2020 May 5;133(9):1025-1031
pubmed: 32044814
JAMA. 2020 Jul 21;324(3):259-269
pubmed: 32511692
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831
Circulation. 2020 Jun 9;141(23):1903-1914
pubmed: 32297796
JAMA Cardiol. 2020 Nov 1;5(11):1265-1273
pubmed: 32730619
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Eur Heart J. 2020 May 14;41(19):1860
pubmed: 32285915
JAMA Pediatr. 2020 Sep 1;174(9):868-873
pubmed: 32392288
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
BMJ. 2020 Jun 3;369:m2094
pubmed: 32493739
N Engl J Med. 2020 Apr 2;382(14):1370-1371
pubmed: 32163697
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
JAMA. 2020 Apr 28;323(16):1612-1614
pubmed: 32191259
Circulation. 2020 Jun 9;141(23):1930-1936
pubmed: 32243205
J Am Heart Assoc. 2017 Sep 9;6(9):
pubmed: 28889100
Eur Heart J Cardiovasc Imaging. 2020 Jul 1;21(7):776
pubmed: 32338706
Circulation. 2020 May 26;141(21):1665-1666
pubmed: 32242749
JAMA Cardiol. 2020 Nov 1;5(11):1281-1285
pubmed: 32730555
JACC Case Rep. 2020 Jul 15;2(9):1331-1336
pubmed: 32368755
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Eur Heart J. 2020 May 14;41(19):1861-1862
pubmed: 32267502
Lancet Respir Med. 2020 Jul;8(7):681-686
pubmed: 32473124
Lancet. 2020 Jun 27;395(10242):e116
pubmed: 32593338
Ann Med. 1997 Aug;29(4):339-43
pubmed: 9375993
Lancet. 2020 May 9;395(10235):1516
pubmed: 32334650
Eur Heart J. 2020 May 14;41(19):1859
pubmed: 32282027
Eur J Heart Fail. 2020 May;22(5):911-915
pubmed: 32275347
JAMA. 2020 Jul 21;324(3):294-296
pubmed: 32511676
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Infection. 2020 Oct;48(5):773-777
pubmed: 32277408